| Title | Intervention |
NCT ID |
Sponsor | Status |
|---|---|---|---|---|
| Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2... | Palbociclib, Letrozole, Fulvestrant, Questionnaire Administration, Quality-of-Life Assessment | NCT03633331 | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors | Manual Therapy | NCT03612531 | M.D. Anderson Cancer Center | Recruiting |
| Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast... | Biospecimen Collection, Screening Mammography | NCT03609021 | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and... | Dexamethasone, Fosaprepitant Dimeglumine, Olanzapine, Ondansetron Hydrochloride, Palonosetron Hydrochloride, Placebo | NCT03578081 | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment | Quality-of-Life Assessment, Questionnaire Administration | NCT03516942 | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| Testing Ramipril to Prevent Memory Loss in People With Glioblastoma | Ramipril | NCT03475186 | Wake Forest University Health Sciences | Recruiting |
| S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast... | Carvedilol, Laboratory Biomarker Analysis, Patient Observation | NCT03418961 | Southwest Oncology Group | Recruiting |
| Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage... | Hypofractionated Radiation Therapy, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration, Radiation Therapy | NCT03414970 | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Treating Pain in Children With Cancer: Pain Buddy | Pain Buddy | NCT03384134 | University of California, Irvine | Recruiting |
| Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-... | Denosumab, Salpingo-Oophorectomy | NCT03382574 | National Cancer Institute (NCI) | Recruiting |
Why I Joined a Clinical Trial
I accepted the offer to be a part of the cancer study since I am young and would love to help other young people facing cancer. I am willing to help any way I can to help make cancer treatments better!